Photo by rawpixel.com on Pexels.com

Canopy Growth Corp (CGC) Technical Analysis for October 26, 2018

Technical Analysis of Canopy Growth Corporation

(By Glenford S. Robinson)

Canopy Growth Corporation (NYSE: CGC) is currently trading at 38.35 as of 9 am Eastern Standard Time, 10/26/2018. The stock is therefore operating in what we (Mstardom Finance Traders) call the red zone (36.71-44.88) or danger zone where it can either go up or down. This is very important for short-term or long-term traders to know. If the trader is in a long-term position, I would think that he or she would be occupying a bullish or long position. However, on the short-term side, I would expect any short positions to be short-term. This thinking was conceived as a result of the overall fundamentals of the company and its stock price including the sector and industry in which it is operating in.

Our proprietary trading strategy or the Mstardom Finance proprietary trading strategy tells us that any price range between 36.71 and 44.88 is a sell signal. However, traders should keep in mind that the closer the price gets to 36.71 is the more likely a reversal could occur. This is why we call this range the danger zone because anything can happen between these price points. This is where candlestick monitoring and stochastic monitoring coupled with a short timeframe is paramount.

Any trader deciding to trade the red zone should stay glued to his or her trading station monitors because any trade executed in this red zone range has a low probability of success from a short-term shorting perspective. Any long-term bullish trade in the red zone is fine, based on the fundamentals of the company. A short-term short position or a short-term long position could be a problem for the less experienced trader.

To be on the safe side of things, we are buyers at the 36.71 and below price point and anything close. For example, at the price point of 38.61, we will become long-term buyers or bulls because we anticipate this trade to be a high probability trade on a long-term basis. We understand that the price could easily go down lower than 38.61, but we are fine with that once we are not using leverage. Leverage is for the professionals. Leverage is when a broker lends money to the trader for him or her to make more trades than the trader’s original money can make. Brokers will liquidate or sell your stock at a loss for you if they think that the stock is losing value. Many accredited investors do not use leverage, and if they do, they use it very sparingly, such as exposing a very small percentage of their portfolio to leveraged or borrowed money.

So, what about the higher ranges or support levels price points? The next price point or hypothetical resistance area is 58.59. Our proprietary trading strategy tells us to become bears at the 58.59 price levels. Therefore, any price anywhere close to 58.59 or higher will turn us into sellers or bears. We must follow our trading strategy because not doing so is a sure way to fail in trading. A trader without a plan has planned to fail in trading the financial markets, and we do not wish to become victims of the financial markets.

Another projected selling price point for CGC is at the 72.23 price level. We will become bears again at the 72.23 level because investors are going to want to take profits a week or days after they have poured in their millions of dollars following a positive news article catalyst.

We will continue with more Technical Analysis for CGC in future Technical Analysis articles.

Disclosure: I/we/us/Mstardom Finance periodically trade CGC stock, but don’t have a position in the stock at this time.

Disclaimer: (c)Mstardom.com; Mstardom, Inc., Mstardom Finance are not financial or investment advisors.

Check Also

GDP Growth Slowed

US Economy Starts to Slow Entering 2019, but Headwinds Ease

The Federal Reserve has signaled that it will postpone further interest rate hikes until signs of rising inflation emerge and cease balance sheet normalization activities towards the end of this year. Stock price gains since the announcement of these policy shifts illustrate that if they are executed, business confidence is likely to rise.

Where can I get business financing?

Horizon Technology Finance Provides Investment Portfolio Update Increases Portfolio Size with $24 Million in Loan Originations; Grows Committed Backlog to $47 Million

"During the third quarter, we experienced solid investment activity, increasing the size of our portfolio and expanding our committed backlog for the second consecutive quarter," said Gerald A. Michaud, President of Horizon. "Our success funding seven loans, totaling more than $24 million, and growing our committed backlog to $47 million underscores the strong demand for our venture debt products to growing life science and technology companies. We believe Horizon will continue to benefit from a robust pipeline of investment opportunities and is well positioned to deliver long-term, disciplined portfolio growth, while ensuring credit quality remains strong."

ECB profit increased in 2018

Financial Statements of the ECB for 2018

The ECB’s net profit is distributed to the euro area national central banks (NCBs). The Governing Council decided to make an interim profit distribution, amounting to €1,191 million, to the euro area NCBs on 31 January 2019. At yesterday’s meeting, the Governing Council decided to distribute the remainder of the profit, amounting to €384 million, on 22 February 2019.

Litigation Photo

Immune Design (IMDZ) Alert: Johnson Fistel Investigates Proposed Sale of Immune Design Corp.; Are Immune Design Shareholders Getting a Fair Deal?

The investigation concerns whether the Immune Design board failed to satisfy its duties to the Company shareholders, including whether the board adequately pursued alternatives to the acquisition and whether the board obtained the best price possible for Immune Design shares of common stock. Nationally recognized Johnson Fistel is investigating whether the proposed deal represents adequate consideration, especially given that one Wall Street analyst has a $9.00 price target on the stock and the Company has approximately $100 million in cash and no long-term debt.

Mergers and Acquisitions

Merck to Acquire Immune Design; Acquisition Bolsters Capabilities in Vaccine Development for Infectious Diseases and Cancer

“Scientists at Immune Design have established a unique portfolio of approaches to cancer immunization and adjuvant systems designed to enhance the ability of a vaccine to protect against infection, which could meaningfully improve vaccine development," said Dr. Roger M. Perlmutter, president, Merck Research Laboratories. “This acquisition builds upon Merck’s industry-leading programs that harness the power of the immune system to prevent and treat disease.”

SEC Files Charges in Elaborate Microcap Stock Fraud

“As alleged in our complaint, Magna Group and its co-defendants used fake debt instruments to unlawfully obtain shares in microcap companies, which they then dumped on unsuspecting retail investors,” said Sanjay Wadhwa, Senior Associate Director of the SEC’s New York Regional Office. “This action demonstrates the resolve of the SEC in pursuing fraudsters who use elaborate financing schemes to engage in securities fraud.”

Investor Alert and Bulletin From SEC Office of Investor Education and Advocacy

Know how to be a better investor. Did you know that active trading and some other very common investing behaviors actually can undermine investment performance? According to researchers, other common investing mistakes include focusing on past performance, favoring investments from your own country, region, state, or company, and holding on to losing investments too long and selling winning investments too soon.

%d bloggers like this: